by Pharmaceutical Technology: Shanghai Green Valley Pharmaceuticals’ new Alzheimer’s disease drug, Oligomannate, has been conditionally approved in China and became available for purchase in late December. This is the first novel Alzheimer’s disease drug to be approved in almost two……
Chinese Alzheimer’s drug to undergo global clinical trials
by Pharmaceutical Technology: Shanghai Green Valley Pharmaceuticals’ new Alzheimer’s disease drug, Oligomannate, has been conditionally approved in China and became available for purchase in late December. This is the first novel Alzheimer’s disease drug to be approved in almost two……